NPI: 1134183171 · WOODRUFF, WI 54568 · Hospitalist Physician · NPI assigned 04/14/2006
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,961 | $536K |
| 2019 | 17,671 | $607K |
| 2020 | 13,308 | $480K |
| 2021 | 12,450 | $336K |
| 2022 | 11,182 | $310K |
| 2023 | 13,718 | $378K |
| 2024 | 9,087 | $261K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 2,645 | 1,997 | $360K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,634 | 3,281 | $343K |
| 41899 | Unlisted procedure, dentoalveolar structures | 798 | 553 | $240K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,000 | 3,469 | $238K |
| 80053 | Comprehensive metabolic panel | 7,031 | 5,755 | $183K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,892 | 3,347 | $177K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,064 | 981 | $132K |
| 99001 | 1,914 | 1,615 | $107K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,593 | 1,114 | $98K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,464 | 804 | $87K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,136 | 985 | $78K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,559 | 1,292 | $76K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 545 | 516 | $71K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 699 | 616 | $59K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 969 | 720 | $52K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 461 | 396 | $52K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,331 | 1,885 | $51K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 342 | 301 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,180 | 5,787 | $51K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 723 | 599 | $46K |
| 81001 | 3,360 | 2,258 | $28K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 175 | 161 | $26K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 705 | 649 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,299 | 1,171 | $22K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,166 | 414 | $21K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 186 | 171 | $21K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 352 | 317 | $19K |
| 80306 | 958 | 825 | $18K | |
| 84484 | 2,168 | 1,654 | $16K | |
| 81025 | 422 | 373 | $14K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 494 | 209 | $13K |
| 83735 | 2,312 | 1,804 | $11K | |
| 80061 | Lipid panel | 782 | 728 | $10K |
| 85610 | 1,730 | 1,376 | $9K | |
| 87070 | 227 | 206 | $9K | |
| 81003 | 1,083 | 923 | $8K | |
| 83690 | 1,263 | 1,053 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 191 | 176 | $7K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 101 | 90 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 110 | 82 | $6K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,815 | 735 | $6K |
| G0378 | Hospital observation service, per hour | 230 | 172 | $4K |
| 71046 | Radiologic examination, chest; 2 views | 1,230 | 1,097 | $4K |
| 83605 | 518 | 407 | $4K | |
| 82947 | 216 | 135 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,611 | 2,181 | $3K |
| 73630 | 179 | 167 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 350 | 325 | $3K |
| 85651 | 884 | 660 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 4,682 | 3,775 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 42 | 38 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 72 | 25 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 178 | 162 | $2K |
| 85730 | 475 | 406 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 63 | 49 | $2K |
| 87040 | 123 | 102 | $1K | |
| 86140 | 370 | 307 | $1K | |
| 84703 | 88 | 80 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 16 | 13 | $1K |
| 85027 | 238 | 198 | $1K | |
| 84145 | 68 | 51 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,932 | 1,559 | $997.96 |
| 71045 | Radiologic examination, chest; single view | 1,544 | 1,327 | $988.02 |
| 86803 | 55 | 54 | $911.27 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 30 | 30 | $834.59 |
| 80076 | 94 | 67 | $776.30 | |
| 73610 | 27 | 25 | $656.08 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 25 | 13 | $578.22 |
| 87807 | 18 | 15 | $571.86 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 16 | 12 | $509.95 |
| 85652 | 184 | 141 | $393.57 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 14 | 12 | $366.85 |
| 82550 | 82 | 53 | $350.63 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,278 | 2,699 | $340.54 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $234.84 |
| 86618 | 12 | 12 | $191.34 | |
| 83880 | 14 | 13 | $170.77 | |
| 85379 | 29 | 25 | $169.59 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,876 | 1,449 | $134.43 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 12 | 12 | $118.92 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 734 | 589 | $94.13 |
| 85007 | 29 | 27 | $84.85 | |
| 87077 | 17 | 12 | $75.15 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,082 | 858 | $74.49 |
| 87186 | 15 | 13 | $71.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,953 | 1,417 | $24.83 |
| J2704 | Injection, propofol, 10 mg | 12 | 12 | $3.53 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 546 | 392 | $0.00 |
| A4641 | Radiopharmaceutical, diagnostic, not otherwise classified | 14 | 13 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | 12 | $0.00 |
| A9270 | Non-covered item or service | 1,384 | 592 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 19 | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 789 | 574 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 91 | 50 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 764 | 562 | $0.00 |
| 96376 | 40 | 24 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 15 | 13 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 66 | 48 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 24 | 13 | $0.00 |